Edgewise Therapeutics, Inc. (EWTX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$43.07+2.67%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · EWTX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| R&D Expenses | 171.3 | 151.4 | 127.0 | 90.9 | 54.0 | 32.2 | 15.0 |
| Operating Income | (218.9) | (191.4) | (158.8) | (114.4) | (71.7) | (43.2) | (17.2) |
| Earnings from Continuing Operations | |||||||
| EBT, Incl. Unusual Items | — | (167.8) | — | (100.2) | — | — | — |
| Income Tax Expense | — | 0.0 | — | 0.0 | 0.0 | 0.0 | — |
| Net Income | |||||||
| Net Income | (29.6) | (167.8) | (133.8) | (0.1) | (67.6) | (42.8) | (17.1) |
| Per Share | |||||||
| Basic EPS | (0.27) | (1.63) | (1.45) | (1.57) | (1.26) | (1.14) | (23.17) |
| Diluted EPS | (0.27) | (1.63) | (1.45) | (1.57) | (1.26) | (1.14) | (23.17) |
| Basic Weighted Avg Shares | 107.7 | 102.9 | 92.4 | 63.7 | 53.6 | 37.5 | 0.7 |
| Diluted Weighted Avg Shares | 107.7 | 102.9 | 92.4 | 63.7 | 53.6 | 37.5 | 0.7 |
| Supplemental | |||||||
| EBIT | (218.9) | (191.4) | (158.8) | (114.4) | (71.7) | (43.2) | (17.2) |
| Effective Tax Rate | — | — | — | -0.0% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.